Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
Scandinavian Journal of Immunology
|
April 19, 2018
UC-1V150, a potent TLR7 agonist capable of activating macrophages and potentiating mAb-mediated target cell deletion
L N Dahal, A Gadd, A D Edwards, et al.
Blood
|
June 25, 1999
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
T M Illidge, M S Cragg, H M McBride, et al.
Cell Death and Differentiation
|
March 14, 2000
Complement mediated cell death is associated with DNA fragmentation
M S Cragg, W J Howatt, L Bloodworth, et al.
The International Journal of Biochemistry & Cell Biology
|
December 9, 2014
Role of the pro-survival molecule Bfl-1 in melanoma
C K Hind, M J Carter, C L Harris, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Therapeutic Immunology
|
August 1, 1995
The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease
L Zhang, R R French, H T Chan, et al.
Cell Biology International
|
November 30, 2005
Segregation of genomes in polyploid tumour cells following mitotic catastrophe
Jekaterina Erenpreisa, M Kalejs, F Ianzini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Immunological Methods to Study Monoclonal Antibody Activity in Chronic Lymphocytic Leukaemia
M J Carter, L N Dahal, K L S Cleary, et al.
Cell Death and Differentiation
|
January 17, 2009
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E M Michalak, E S Jansen, L Happo, et al.
Cell Death and Differentiation
|
July 18, 2015
BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma
M J Carter, K L Cox, S J Blakemore, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
Scandinavian Journal of Immunology
|
April 19, 2018
UC-1V150, a potent TLR7 agonist capable of activating macrophages and potentiating mAb-mediated target cell deletion
L N Dahal, A Gadd, A D Edwards, et al.
Blood
|
June 25, 1999
The importance of antibody-specificity in determining successful radioimmunotherapy of B-cell lymphoma
T M Illidge, M S Cragg, H M McBride, et al.
Cell Death and Differentiation
|
March 14, 2000
Complement mediated cell death is associated with DNA fragmentation
M S Cragg, W J Howatt, L Bloodworth, et al.
The International Journal of Biochemistry & Cell Biology
|
December 9, 2014
Role of the pro-survival molecule Bfl-1 in melanoma
C K Hind, M J Carter, C L Harris, et al.
Journal of Immunological Methods
|
June 16, 2010
Validation of an ELISA for the determination of rituximab pharmacokinetics in clinical trials subjects
G Hampson, T H Ward, J Cummings, et al.
Therapeutic Immunology
|
August 1, 1995
The development of anti-CD79 monoclonal antibodies for treatment of B-cell neoplastic disease
L Zhang, R R French, H T Chan, et al.
Cell Biology International
|
November 30, 2005
Segregation of genomes in polyploid tumour cells following mitotic catastrophe
Jekaterina Erenpreisa, M Kalejs, F Ianzini, et al.
Methods in Molecular Biology (Clifton, N.J.)
|
October 24, 2018
Immunological Methods to Study Monoclonal Antibody Activity in Chronic Lymphocytic Leukaemia
M J Carter, L N Dahal, K L S Cleary, et al.
Cell Death and Differentiation
|
January 17, 2009
Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis
E M Michalak, E S Jansen, L Happo, et al.
Cell Death and Differentiation
|
July 18, 2015
BCR-signaling-induced cell death demonstrates dependency on multiple BH3-only proteins in a murine model of B-cell lymphoma
M J Carter, K L Cox, S J Blakemore, et al.
Page
of 3